Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:55 UTC
  • 1
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:53 UTC
  • 1
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:52 UTC
  • 1
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:50 UTC
  • 1
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:49 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (EAA)

  • SEC News
  • April 02, 2026, 02:48 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 02, 2026, 02:41 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 02, 2026, 02:41 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 02, 2026, 02:41 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 02, 2026, 02:41 UTC
  • 1
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text
  • Previous
  • 541
  • 542
  • 543
  • 544
  • 545
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228334)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140712)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin